Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cipla
AstraZeneca
Dow
Federal Trade Commission
Moodys
McKesson
Deloitte
UBS

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021163

« Back to Dashboard

NDA 021163 describes INFUVITE ADULT, which is a drug marketed by Sandoz Inc and is included in two NDAs. It is available from one supplier. Additional details are available on the INFUVITE ADULT profile page.

The generic ingredient in INFUVITE ADULT is alpha-tocopherol acetate; ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin k. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alpha-tocopherol acetate; ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin k profile page.
Summary for 021163
You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A PALMITATE','VITAMIN K') AND hsdb_dru' at line 1
Tradename:INFUVITE ADULT
Applicant:Sandoz Inc
Ingredient:alpha-tocopherol acetate; ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin k
Patents:0